XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements Of Stockholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Mar. 31, 2022   280,051      
Beginning balance at Mar. 31, 2022 $ 7,625 $ 3 $ 0 $ 7,607 $ 15
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Total comprehensive income (loss) 720     802 (82)
Stock-based compensation 548   548    
Issuance of common stock (in shares)   3,311      
Issuance of common stock (95)   (95)    
Repurchase and retirement of common stock (in shares)   (10,448)      
Common stock repurchases (1,295)   (453) (842)  
Cash dividends declared (210)     (210)  
Ending balance (in shares) at Mar. 31, 2023   272,914      
Ending balance at Mar. 31, 2023 7,293 $ 3 0 7,357 (67)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Total comprehensive income (loss) 1,268     1,273 (5)
Stock-based compensation 584   584    
Issuance of common stock (in shares)   3,496      
Issuance of common stock (119)   (119)    
Repurchase and retirement of common stock (in shares)   (9,995)      
Common stock repurchases (1,308)   (465) (843)  
Cash dividends declared $ (205)     (205)  
Ending balance (in shares) at Mar. 31, 2024 266,000 266,415      
Ending balance at Mar. 31, 2024 $ 7,513 $ 3 0 7,582 (72)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Total comprehensive income (loss) 1,106     1,121 (15)
Stock-based compensation 642   642    
Issuance of common stock (in shares)   3,532      
Issuance of common stock (156)   (156)    
Repurchase and retirement of common stock (in shares)   (17,632)      
Common stock repurchases (2,520)   (486) (2,034)  
Cash dividends declared $ (199)     (199)  
Ending balance (in shares) at Mar. 31, 2025 252,000 252,315      
Ending balance at Mar. 31, 2025 $ 6,386 $ 3 $ 0 $ 6,470 $ (87)